InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,605.36
(
-1.22%
)
Post# of 253171
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

57_2001

Send PM Follow Ignore
Followers 2
Posts 538
Boards Moderated 0
Alias Born 03/05/2017

57_2001

Re: randychub post# 234773

Friday, 09/25/2020 2:12:09 PM

Friday, September 25, 2020 2:12:09 PM

Post# of 253171
not sure, however if it is going well,
i would think they would keep recruiting.

perhaps someone with experience in clinic trials could
take a look.

https://www.humanigen.com/press/Humanigen-Announces-Review-of-Lenzilumab-Phase-3-Study-in-COVID-19-by-Data-Safety-Monitoring-Board
see by this data in fourth qt.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up